However, ZOL pre-treatment of the hepatoma cell lines increased IFN-γ expression by the intratumoural Vγ9Vδ2 T-cells, predominantly by the Vγ9Vδ2 TRM subset (Fig. 6f, g). This evidence concerns the gene IFNG and hepatocellular carcinoma.